FMED | XLV | FMED / XLV | |
Gain YTD | 1.455 | 1.108 | 131% |
Net Assets | 55.8M | 34.3B | 0% |
Total Expense Ratio | 0.50 | 0.08 | 625% |
Turnover | 30.00 | 2.00 | 1,500% |
Yield | 0.46 | 1.74 | 26% |
Fund Existence | 5 years | 27 years | - |
FMED | XLV | |
---|---|---|
RSI ODDS (%) | 4 days ago90% | N/A |
Stochastic ODDS (%) | 4 days ago89% | 4 days ago73% |
Momentum ODDS (%) | 4 days ago77% | 4 days ago75% |
MACD ODDS (%) | 4 days ago77% | 4 days ago81% |
TrendWeek ODDS (%) | 4 days ago80% | 4 days ago82% |
TrendMonth ODDS (%) | 4 days ago82% | 4 days ago84% |
Advances ODDS (%) | 4 days ago81% | 4 days ago82% |
Declines ODDS (%) | 11 days ago80% | 12 days ago82% |
BollingerBands ODDS (%) | 4 days ago90% | 4 days ago74% |
Aroon ODDS (%) | N/A | 4 days ago81% |
A.I.dvisor indicates that over the last year, FMED has been closely correlated with RGEN. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if FMED jumps, then RGEN could also see price increases.
Ticker / NAME | Correlation To FMED | 1D Price Change % | ||
---|---|---|---|---|
FMED | 100% | +1.17% | ||
RGEN - FMED | 68% Closely correlated | +3.30% | ||
DHR - FMED | 66% Closely correlated | +0.59% | ||
ISRG - FMED | 65% Loosely correlated | +2.71% | ||
TECH - FMED | 64% Loosely correlated | +2.82% | ||
BSX - FMED | 63% Loosely correlated | -0.07% | ||
More |
A.I.dvisor indicates that over the last year, XLV has been closely correlated with TMO. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then TMO could also see price increases.
Ticker / NAME | Correlation To XLV | 1D Price Change % | ||
---|---|---|---|---|
XLV | 100% | +0.34% | ||
TMO - XLV | 70% Closely correlated | +0.64% | ||
DHR - XLV | 66% Closely correlated | +0.59% | ||
MTD - XLV | 66% Closely correlated | +1.39% | ||
RVTY - XLV | 66% Loosely correlated | +1.10% | ||
TECH - XLV | 65% Loosely correlated | +2.82% | ||
More |